2. Academic Validation
  3. Selective PI3Kδ inhibitor TYM-3-98 suppresses AKT/mTOR/SREBP1-mediated lipogenesis and promotes ferroptosis in KRAS-mutant colorectal cancer

Selective PI3Kδ inhibitor TYM-3-98 suppresses AKT/mTOR/SREBP1-mediated lipogenesis and promotes ferroptosis in KRAS-mutant colorectal cancer

  • Cell Death Dis. 2024 Jul 3;15(7):474. doi: 10.1038/s41419-024-06848-7.
Ya-Nan Zheng # 1,  Si-Yue Lou # 1 2,  Jun Lu 1,  Fan-Li Zheng 1 3,  Yong-Mei Tang 4,  En-Jun Zhang 1,  Sun-Liang Cui 5,  Hua-Jun Zhao 6 7
Affiliations

Affiliations

  • 1 School of Pharmaceutical Sciences, Zhejiang Chinese Medical University, Hangzhou, China.
  • 2 Academy of Chinese Medical Sciences, Zhejiang Chinese Medical University, Hangzhou, Zhejiang, China.
  • 3 Department of Pharmacology, Zhejiang University School of Medicine, Hangzhou, People's Republic of China.
  • 4 Institute of Drug Discovery and Design, College of Pharmaceutical Sciences, Zhejiang University, Hangzhou, China.
  • 5 Institute of Drug Discovery and Design, College of Pharmaceutical Sciences, Zhejiang University, Hangzhou, China. slcui@zju.edu.cn.
  • 6 School of Pharmaceutical Sciences, Zhejiang Chinese Medical University, Hangzhou, China. zhj@zcmu.edu.cn.
  • 7 Academy of Chinese Medical Sciences, Zhejiang Chinese Medical University, Hangzhou, Zhejiang, China. zhj@zcmu.edu.cn.
  • # Contributed equally.
PMID: 38956060 DOI: 10.1038/s41419-024-06848-7
Abstract

Colorectal Cancer (CRC) is one of the most common tumors of the digestive system worldwide. KRAS mutations limit the use of anti-EGFR Antibodies in combination with chemotherapy for the treatment of CRC. Therefore, novel targeted therapies are needed to overcome the KRAS-induced oncogenesis. Recent evidence suggests that inhibition of PI3K led to Ferroptosis, a nonapoptotic cell death closely related to KRAS-mutant cells. Here, we showed that a selective PI3Kδ Inhibitor TYM-3-98 can suppress the Akt/mTOR signaling and activate the Ferroptosis pathway in KRAS-mutant CRC cells in a concentration-dependent manner. This was evidenced by the lipid peroxidation, iron accumulation, and depletion of GSH. Moreover, the overexpression of the sterol regulatory element-binding protein 1 (SREBP1), a downstream transcription factor regulating lipid metabolism, conferred CRC cells greater resistance to Ferroptosis induced by TYM-3-98. In addition, the effect of TYM-3-98 was confirmed in a xenograft mouse model, which demonstrated significant tumor suppression without obvious hepatoxicity or renal toxicity. Taken together, our work demonstrated that the induction of Ferroptosis contributed to the PI3Kδ inhibitor-induced cell death via the suppression of Akt/mTOR/SREBP1-mediated lipogenesis, thus displaying a promising therapeutic effect of TYM-3-98 in CRC treatment.

Figures
Products
嗨！很高兴为您提供帮助！

尊敬的 MCE 客户您好，
请您选择所在区域，我们将转接对应客服为您服务！

热门区域

A

B

C

F

G

H

J

L

N

Q

S

T

X

Y

Z

热 A B C F G H J L N Q S T X Y Z